John Dahldorf

John Dahldorf

Directeur/Membre du Conseil chez HYPERFINE, INC.

Fortune : 26 441 $ au 30/06/2026

69 ans
Health Technology
Distribution Services
Consumer Services

Profil

Mr. John T.
Dahldorf
is an Independent Director at Hyperfine, Inc. and a Chief Financial Officer at Q'Apel Medical, Inc. He is on the Board of Directors at Hyperfine, Inc. and Fyodor Biotechnologies, Inc. Mr. Dahldorf was previously employed as a Chief Financial Officer by Adagio Medical Holdings, Inc., a Chief Financial Officer by Adagio Medical, Inc., a Chief Financial Officer by Harmony Foods LLC, a Chief Financial Officer by Scn Bestco, a Chief Financial Officer by Benvenue Medical, Inc., a Chief Financial Officer by Acutus Medical, Inc., a Chief Financial Officer by Volcano Corp., a Co-Chief Executive Officer by Digirad Corp., a Finance Director by Arrow Electronics, Inc., and a Chief Finance Officer & General Manager by Volcano Therapeutics, Inc. He received his undergraduate degree from Western Illinois University and an MBA from Western Illinois University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/05/2026 19 586 ( 0,02 % ) 26 441 $ 30/06/2026

Postes actifs de John Dahldorf

SociétésPosteDébut
HYPERFINE, INC. Directeur/Membre du Conseil 22/12/2021
Directeur/Membre du Conseil -
Directeur Financier/CFO -

Anciens postes connus de John Dahldorf

SociétésPosteFin
Directeur Financier/CFO 01/03/2025
Directeur Financier/CFO 01/03/2023
ACUTUS MEDICAL, INC. Directeur Financier/CFO 01/01/2017
Voir l'expérience en détail de John Dahldorf

Formation de John Dahldorf

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

54

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John Dahldorf
🔇